Information
PlasmAccelerate revolutionizes cancer therapy by combining biomaterials with cold plasma technology. Cold plasma selectively targets cancer cells without harming healthy tissue. Its effects can be transferred to biocompatible liquids or hydrogels for localized action and synergy with other therapies, addressing unmet clinical needs. Our current focus is bone cancer, with potential applications in other indications.
Key Information
-
Not a Startup
Growth Stage
-
CountrySpain
-
Founding Year2025